Lowery DM, Clauser KR, Hjerrild M, et al. Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate. EMBO J. 2007;26(9):2262-73. doi:10.1038/sj.emboj.7601683.

Hu X, Daly M. What have we learned from six years of GWAS in autoimmune diseases, and what is next?. Curr Opin Immunol. 2012;24(5):571-5. doi:10.1016/j.coi.2012.09.001.

Pers TH, Dworzyński P, Thomas CE, Lage K, Brunak S. MetaRanker 2.0: a web server for prioritization of genetic variation data. Nucleic Acids Res. 2013;41(Web Server issue):W104-8. doi:10.1093/nar/gkt387.

Börnigen D, Pers TH, Thorrez L, Huttenhower C, Moreau Y, Brunak S. Concordance of gene expression in human protein complexes reveals tissue specificity and pathology. Nucleic Acids Res. 2013;41(18):e171. doi:10.1093/nar/gkt661.

Hill SJ, Rolland T, Adelmant G, et al. Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev. 2014;28(17):1957-75. doi:10.1101/gad.241620.114.

Kamburov A, Lawrence MS, Polak P, et al. Comprehensive assessment of cancer missense mutation clustering in protein structures. Proc Natl Acad Sci U S A. 2015;112(40):E5486-95. doi:10.1073/pnas.1516373112.

Marbach D, Lamparter D, Quon G, Kellis M, Kutalik Z, Bergmann S. Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods. 2016;13(4):366-70. doi:10.1038/nmeth.3799.

Cao Z, Conway KL, Heath RJ, et al. Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation. Immunity. 2015;43(4):715-26. doi:10.1016/j.immuni.2015.10.005.

Karanicolas J, Corn JE, Chen I, et al. A de novo protein binding pair by computational design and directed evolution. Mol Cell. 2011;42(2):250-60. doi:10.1016/j.molcel.2011.03.010.

Holson EB, Schreiber SL. Chemoproteomics quantifies complexity. Nat Biotechnol. 2011;29(3):235-6. doi:10.1038/nbt.1804.